<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
69693-519-24
</NDCCode>
<PackageDescription>
2 BLISTER PACK in 1 CARTON (69693-519-24) / 99.5 mg in 1 BLISTER PACK
</PackageDescription>
<NDC11Code>
69693-0519-24
</NDC11Code>
<ProductNDC>
69693-519
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Cystex Max Strength Uti Pain Relief
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Cystex Max Strength Uti Pain Relief
</NonProprietaryName>
<DosageFormName>
TABLET
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20260727
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH DRUG
</MarketingCategoryName>
<ApplicationNumber>
505G(a)(3)
</ApplicationNumber>
<LabelerName>
Clarion Brands LLC
</LabelerName>
<SubstanceName>
PHENAZOPYRIDINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
99.5
</StrengthNumber>
<StrengthUnit>
mg/99.5mg
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2026-07-28
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20271231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20260727
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>